John Vissing

Medicine & Life Sciences

1. Muscles 100%
2. Glycogen Storage Disease Type V 73%
3. Exercise 60%
4. Mutation 45%
5. Mitochondrial Myopathies 38%
6. Muscular Diseases 35%
7. Limb-Girdle Muscular Dystrophies 33%
8. Mitochondrial DNA 30%
9. Fats 28%
10. Skeletal Muscle 26%
11. Myotonia Congenita 24%
12. Phenotype 23%
13. Myasthenia Gravis 22%
14. Muscle Strength 22%
15. Glucose 20%
16. Myotonic Dystrophy 19%
17. Glycogen Storage Disease 19%
18. Facioscapulohumeral Muscular Dystrophy 18%
19. Genes 18%
20. Muscle Weakness 17%
21. Muscular Dystrophy, Limb-Girdle, Type 2I 17%
22. Glycogen 17%
23. Duchenne Muscular Dystrophy 16%
24. Muscular Dystrophies 16%
25. Glycogen Storage Disease Type II 15%
26. Limb-girdle muscular dystrophy type 2A 14%
27. Placebos 14%
28. X-Linked Bulbo-Spinal Atrophy 13%
29. eculizumab 12%
30. Lactic Acid 12%
31. Oculopharyngeal Muscular Dystrophy 12%
32. Biopsy 11%
33. Glycogenolysis 10%
34. Exercise Tolerance 10%
35. Walk Test 10%
36. Neuromuscular Diseases 10%
37. Fatigue 10%
38. Paraspinal Muscles 9%
39. Workload 9%
40. Late Onset Disorders 9%
41. Anoctamins 9%
42. Creatine Kinase 9%
43. Safety 9%
44. Walking 8%
45. Denmark 8%
46. Mitochondrial Diseases 8%
47. Myotonia 7%
48. Magnetic Resonance Imaging 7%
49. Dimauro disease 7%
50. Exercise Test 7%